Janssen-Cilag International NV announced that XEPLION® (paliperidone palmitate), a once monthly, long-acting injectable, antipsychotic, has received approval from the European Commission for the treatment of schizophrenia. Schizophrenia is relatively common and the prevalence is similar around the world...